PubMed

Clinical Implications of Recent Findings from the Antihypertensive and Lipid-Lowering Treatment To Prevent Heart Attack Trial (ALLHAT) and Other Studies of Hypertension.

Furberg CD, Psaty BM, Pahor M, Alderman MH.

Ann Intern Med. 2001 Dec 18;135(12):1074-8. Review.PMID: 11747386 [PubMed - indexed for MEDLINE]Related articlesFree article

Major cardiovascular events in hypertensive patients randomized to doxazosin vs chlorthalidone: the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT). ALLHAT Collaborative Research Group.

[No authors listed]

JAMA. 2000 Apr 19;283(15):1967-75. Erratum in: JAMA 2002 Dec 18;288(23):2976. PMID: 10789664 [PubMed - indexed for MEDLINE]Related articlesFree article

Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).

ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial.

JAMA. 2002 Dec 18;288(23):2981-97. Erratum in: JAMA 2003 Jan 8;289(2):178. JAMA. 2004 May 12;291(18):2196. PMID: 12479763 [PubMed - indexed for MEDLINE]Related articlesFree article

Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies.

Law MR, Morris JK, Wald NJ.

BMJ. 2009 May 19;338:b1665. doi: 10.1136/bmj.b1665. Review.PMID: 19454737 [PubMed - indexed for MEDLINE]Related articlesFree article

Update on the management of hypertension: recent clinical trials and the JNC 7.

Moser M.

J Clin Hypertens (Greenwich). 2004 Oct;6(10 Suppl 2):4-13. Review.PMID: 15470293 [PubMed - indexed for MEDLINE]Related articles

Blood pressure lowering, not vascular mechanism of action, is the primary determinant of clinical outcome.

Leenen FH.

Can J Cardiol. 2004 Aug;20 Suppl B:77B-82B. Review.PMID: 15309209 [PubMed - indexed for MEDLINE]Related articles

[Calcium antagonists in cardiovascular disease. Clinical evidence from morbidity and mortality trials]

Oparil S, Bakir SE.

Drugs. 2000;59 Spec No 2:25-37. Review. French. PMID: 11002856 [PubMed - indexed for MEDLINE]Related articles

The role of angiotensin II type 1 receptor antagonists in elderly patients with hypertension.

Thomas GN, Chan P, Tomlinson B.

Drugs Aging. 2006;23(2):131-55. Review.PMID: 16536636 [PubMed - indexed for MEDLINE]Related articles

Experimental approaches to determining the choice of first-step therapy for patients with hypertension. The ALLHAT Research Group Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial.

Whelton PK, Williamson JD, Louis GT, Davis BR, Cutler JA.

Clin Exp Hypertens. 1996 Apr-May;18(3-4):569-79. Review.PMID: 8743044 [PubMed - indexed for MEDLINE]Related articles

Cardiovascular prevention and blood pressure reduction: a quantitative overview updated until 1 March 2003.

Staessen JA, Wang JG, Thijs L.

J Hypertens. 2003 Jun;21(6):1055-76.PMID: 12777939 [PubMed - indexed for MEDLINE]Related articles

Fasting glucose levels and incident diabetes mellitus in older nondiabetic adults randomized to receive 3 different classes of antihypertensive treatment: a report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).

Barzilay JI, Davis BR, Cutler JA, Pressel SL, Whelton PK, Basile J, Margolis KL, Ong ST, Sadler LS, Summerson J; ALLHAT Collaborative Research Group.

Arch Intern Med. 2006 Nov 13;166(20):2191-201.PMID: 17101936 [PubMed - indexed for MEDLINE]Related articlesFree article

Relationship of antihypertensive treatment regimens and change in blood pressure to risk for heart failure in hypertensive patients randomly assigned to doxazosin or chlorthalidone: further analyses from the Antihypertensive and Lipid-Lowering treatment to prevent Heart Attack Trial.

Davis BR, Cutler JA, Furberg CD, Wright JT, Farber MA, Felicetta JV, Stokes JD; ALLHAT Collaborative Research Group.

Ann Intern Med. 2002 Sep 3;137(5 Part 1):313-20.PMID: 12204014 [PubMed - indexed for MEDLINE]Related articlesFree article

Health outcomes associated with various antihypertensive therapies used as first-line agents: a network meta-analysis.

Psaty BM, Lumley T, Furberg CD, Schellenbaum G, Pahor M, Alderman MH, Weiss NS.

JAMA. 2003 May 21;289(19):2534-44.PMID: 12759325 [PubMed - indexed for MEDLINE]Related articlesFree article

Calcium channel blockers in the treatment of hypertension and prevention of cardiovascular disease: results from major clinical trials.

Black HR.

Clin Cornerstone. 2004;6(4):53-66. Review.PMID: 15850766 [PubMed - indexed for MEDLINE]Related articles

Cardiovascular protection and blood pressure reduction: a meta-analysis.

Staessen JA, Wang JG, Thijs L.

Lancet. 2001 Oct 20;358(9290):1305-15. Erratum in: Lancet 2002 Jan 26;359(9303):360. PMID: 11684211 [PubMed - indexed for MEDLINE]Related articles

Rationale and design for the Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). ALLHAT Research Group.

Davis BR, Cutler JA, Gordon DJ, Furberg CD, Wright JT Jr, Cushman WC, Grimm RH, LaRosa J, Whelton PK, Perry HM, Alderman MH, Ford CE, Oparil S, Francis C, Proschan M, Pressel S, Black HR, Hawkins CM.

Am J Hypertens. 1996 Apr;9(4 Pt 1):342-60.PMID: 8722437 [PubMed - indexed for MEDLINE]Related articles

What ALLHAT tells us about treating high-risk patients with hypertension and hyperlipidemia.

Geraci TS, Geraci SA.

J Cardiovasc Nurs. 2003 Nov-Dec;18(5):389-95. Review.PMID: 14680343 [PubMed - indexed for MEDLINE]Related articles

Current treatment of patients with hypertension: therapeutic implications of INSIGHT.

Taddei S, Ghiadoni L, Salvetti A.

Drugs. 2003;63(14):1435-44. Review.PMID: 12834362 [PubMed - indexed for MEDLINE]Related articles

Clinical events in high-risk hypertensive patients randomly assigned to calcium channel blocker versus angiotensin-converting enzyme inhibitor in the antihypertensive and lipid-lowering treatment to prevent heart attack trial.

Leenen FH, Nwachuku CE, Black HR, Cushman WC, Davis BR, Simpson LM, Alderman MH, Atlas SA, Basile JN, Cuyjet AB, Dart R, Felicetta JV, Grimm RH, Haywood LJ, Jafri SZ, Proschan MA, Thadani U, Whelton PK, Wright JT; Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial Collaborative Research Group.

Hypertension. 2006 Sep;48(3):374-84. Epub 2006 Jul 24.PMID: 16864749 [PubMed - indexed for MEDLINE]Related articlesFree article

Clinical outcomes by race in hypertensive patients with and without the metabolic syndrome: Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).

Wright JT Jr, Harris-Haywood S, Pressel S, Barzilay J, Baimbridge C, Bareis CJ, Basile JN, Black HR, Dart R, Gupta AK, Hamilton BP, Einhorn PT, Haywood LJ, Jafri SZ, Louis GT, Whelton PK, Scott CL, Simmons DL, Stanford C, Davis BR.

Arch Intern Med. 2008 Jan 28;168(2):207-17.PMID: 18227370 [PubMed - indexed for MEDLINE]Related articlesFree article